World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
116
Citations
62304
World Ranking
177
National Ranking
82

Medicine

D-Index
117
Citations
62511
World Ranking
4146
National Ranking
2272

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award

Overview

Robert A. Bonomo is affiliated with Case Western Reserve University in the United States. Their research spans several key areas within biochemistry, genetics, molecular biology, and medicine, with a particular focus on molecular medicine, epidemiology, pharmacology, molecular biology, and endocrinology.

The scientist's work covers a spectrum of topics related to bacterial infections and antibiotic resistance. Major areas of research include:

  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Use and Resistance
  • Vibrio bacteria research studies
  • Bacterial biofilms and quorum sensing
  • Pneumonia and Respiratory Infections
  • Tuberculosis Research and Epidemiology

Frequent publication venues where their work appears include:

  • Antimicrobial Agents and Chemotherapy
  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • mBio

Robert A. Bonomo has co-authored extensively, collaborating most often with the following researchers:

  • David van Duin
  • Christopher R. Bethel
  • Andrea M. Hujer
  • María Soledad Ramírez
  • Alejandro J. Vila

Among their recent scientific papers are the following publications:

  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine), 2021, Clinical Microbiology and Infection
  • Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections, 2023, Clinical Infectious Diseases
  • Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections, 2021, Clinical Infectious Diseases
  • Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa), 2022, Clinical Infectious Diseases
  • Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa), 2020, Clinical Infectious Diseases

The scientist's profile demonstrates a multidisciplinary approach to infectious diseases, addressing challenges related to antimicrobial resistance in Gram-negative bacteria through extensive clinical guidance and epidemiological research. The focus on bacterial pathogens such as Acinetobacter baumannii, Stenotrophomonas maltophilia, and Pseudomonas aeruginosa highlights a commitment to understanding and combating difficult-to-treat infections.

Best Publications

  • Extended-spectrum beta-lactamases: a clinical update.

    David L. Paterson;Robert A. Bonomo

  • Three Decades of β-Lactamase Inhibitors

    Sarah M. Drawz;Robert A. Bonomo;Robert A. Bonomo

  • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

    L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber

  • Carbapenems: Past, Present, and Future

    Krisztina M. Papp-Wallace;Andrea Endimiani;Andrea Endimiani;Andrea Endimiani;Magdalena A. Taracila;Robert A. Bonomo

  • Global Challenge of Multidrug-Resistant Acinetobacter baumannii

    Federico Perez;Andrea M. Hujer;Kristine M. Hujer;Brooke K. Decker

  • Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

    Darren Wong;Travis B. Nielsen;Robert A. Bonomo;Paul Pantapalangkoor

  • Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa

    Robert A. Bonomo;Dora Szabo

  • International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections

    David L. Paterson;Wen Chien Ko;Anne Von Gottberg;Sunlta Mohapatra

  • 10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

    Helen W. Boucher;George H. Talbot;Daniel K. Benjamin;Daniel K. Benjamin;John Bradley;John Bradley

  • Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

    Curtis J. Donskey;Tanvir K. Chowdhry;Michelle T. Hecker;Claudia K. Hoyen

  • Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum β-Lactamases

    David L. Paterson;David L. Paterson;Wen Chien Ko;Anne Von Gottberg;Sunita Mohapatra

  • Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory

    David L. Paterson;David L. Paterson;Wen-Chien Ko;Anne Von Gottberg;Jose Maria Casellas

  • Better tests, better care: improved diagnostics for infectious diseases.

    Angela M. Caliendo;David N. Gilbert;David N. Gilbert;Christine C. Ginocchio;Kimberly E. Hanson

  • Carbapenemase-Producing Organisms: A Global Scourge

    Robert A Bonomo;Robert A Bonomo;Eileen M Burd;John Conly;Brandi M Limbago

  • Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center

    Kristine M. Hujer;Andrea M. Hujer;Edward A. Hulten;Saralee Bajaksouzian

  • Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

    David Van Duin;Judith J. Lok;Michelle Earley;Eric Cober

  • Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding

    Liang Chen;Barun Mathema;Kalyan D. Chavda;Frank R. DeLeo

  • Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

    Belén Gutiérrez-Gutiérrez;Elena Salamanca;Marina de Cueto;Po-Ren Hsueh

  • Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations.

    David van Duin;Robert A. Bonomo

  • Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii

    Mark D. Adams;Karrie Goglin;Neil Molyneaux;Kristine M. Hujer

  • Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system

    Mark D. Adams;Gabrielle C. Nickel;Saralee Bajaksouzian;Heather Lavender

  • Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases

    David L. Paterson;Kristine M. Hujer;Andrea M. Hujer;Bethany Yeiser

Frequent Co-Authors

Andrea M. Hujer
Andrea M. Hujer United States Department of Veterans Affairs
Federico Perez
Federico Perez Case Western Reserve University
Kristine M. Hujer
Kristine M. Hujer Case Western Reserve University
Michael R. Jacobs
Michael R. Jacobs University Hospitals of Cleveland
Barry N. Kreiswirth
Barry N. Kreiswirth Center for Discovery and Innovation
Krisztina M. Papp-Wallace
Krisztina M. Papp-Wallace Case Western Reserve University
Andrea Endimiani
Andrea Endimiani University of Bern
David L. Paterson
David L. Paterson University of Queensland
Liang Chen
Liang Chen Hackensack Meridian Health Center for Discovery and Innovation
Vance G. Fowler
Vance G. Fowler Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology opens up diverse career options in healthcare, research, and technology. For instance, becoming a Child Life Specialist requires specialized training and certification, such as obtaining a ccls certification, which complements microbiology knowledge in pediatrics and patient care settings.

Those with a criminal background can also pursue stable educational paths. Resources like college degrees for felons highlight accessible programs that support career growth despite past challenges, making microbiology-related fields more attainable to a wider audience.

Healthcare professionals aiming to expand their scope might consider roles such as a Functional Medicine Nurse Practitioner, where understanding pathogens and the human microbiome can be critical. The functional medicine np salary reflects the growing demand in this innovative healthcare field.

Additionally, skills in medical coding and billing are essential to healthcare operations. Pursuing a credential like certified professional coder (cpc) can lead to rewarding positions that combine analytical expertise with healthcare knowledge.

Best Scientists Citing Robert A. Bonomo

Trending Scientists

Recently Published Articles